摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-methyl-2,3,4,9-tetrahydropyrido[3,4-b]indol-7-one

中文名称
——
中文别名
——
英文名称
1-methyl-2,3,4,9-tetrahydropyrido[3,4-b]indol-7-one
英文别名
——
1-methyl-2,3,4,9-tetrahydropyrido[3,4-b]indol-7-one化学式
CAS
——
化学式
C12H12N2O
mdl
——
分子量
200.24
InChiKey
CRQDWQWZCNKKAC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    41.1
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • COMPOSITION COMPRISING RAPHANUS, THEOBROMA AND PASSIFLORA FOR TREATING OPIOID AND ALCOHOL ABUSE
    申请人:Arabian German Medical Products Co. W.L.L.
    公开号:EP2934561A1
    公开(公告)日:2015-10-28
  • PRE-OPERATIVE BEVERAGES
    申请人:Santé, LLC
    公开号:US20150283072A1
    公开(公告)日:2015-10-08
    The invention provides a formulated beverage composition that can be administered to a patient, prior to anesthesia, sedation and/or surgical or dental operation, to reduce the risk of aspiration pneumonia while simultaneously improving the well-being of the patient. The beverage composition is designed to be taken orally, by a patient, within a specified short period of time prior to administration of an anesthesia and/or sedative/analgesic. Further described herein is the method of using the beverage composition. The method may include providing a written label of instructions affixed to the beverage container which instructions positively direct the patient's ingestion of the beverage composition.
  • US9821018B2
    申请人:——
    公开号:US9821018B2
    公开(公告)日:2017-11-21
  • [EN] COMPOSITION COMPRISING RAPHANUS, THEOBROMA AND PASSIFLORA FOR TREATING OPIOID AND ALCOHOL ABUSE<br/>[FR] COMPOSITION COMPRENANT DU RAPHANUS, DU THEOBROMA ET DE LA PASSIFLORA POUR LE TRAITEMENT DE L'ABUS D'OPIOÏDES ET D'ALCOOL
    申请人:ARABIAN GERMAN MEDICAL PRODUCTS CO W L L
    公开号:WO2014097259A1
    公开(公告)日:2014-06-26
    The present invention relates to a composition comprising a) an extract of a plant belonging to the genus Raphanus, wherein said extract is obtainable or obtained by extracting at least the air roots, seeds and/or bulbs with a hydrophilic, medium-polar and/or lipophilic solvent; b) an extract of a plant belonging to the genus Theobroma, wherein said extract is obtainable or obtained by extracting at least the fruit with a hydrophilic and/or medium-polar solvent, and c) an extract of a plant belonging to the genus Passiflora, wherein said extract is obtainable or obtained by extracting at least the flower with a hydrophilic, medium-polar and/or lipophilic solvent, its use in treating opioid abuse, opioid dependency, alcohol dependency and/or alcohol abuse and/or for use in treating the symptoms of opioid and/or alcohol withdrawal, and a method for its production.
  • [EN] PRE-OPERATIVE BEVERAGES<br/>[FR] BOISSONS PRÉOPÉRATOIRES
    申请人:SANTÉ LLC
    公开号:WO2015142611A1
    公开(公告)日:2015-09-24
    The invention provides a formulated beverage composition that can be administered to a patient, prior to anesthesia, sedation and/or surgical or dental operation, to reduce the risk of aspiration pneumonia while simultaneously improving the well-being of the patient. The beverage composition is designed to be taken orally, by a patient, within a specified short period of time prior to administration of an anesthesia and/or sedative/analgesic. Further described herein is the method of using the beverage composition. The method may include providing a written label of instructions affixed to the beverage container which instructions positively direct the patient's ingestion of the beverage composition.
查看更多